Advertisement

Topics

Otonomy Inc. Company Profile

16:51 EST 19th November 2017 | BioPortfolio

Otonomy is an emerging biopharmaceutical company based in San Diego that is focused on the development and commercialization of novel treatments for diseases of the inner and middle ear. This field represents a large untapped opportunity with nearly 30 million Americans facing debilitating hearing and balance disorders. Currently, no approved drug treatments exist for these conditions. In addition, more than 5 million annual cases of ear infection are still treated with resistance-causing oral antibiotics or locally administered drugs that require surgical perforation of the ear drum. Otonomy is working in partnership with leading experts in the field to bring new drug therapies to these unserved patients. For more information, visit www.otonomy.com.


News Articles [46 Associated News Articles listed on BioPortfolio]

OTONOMY INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Otonomy, Inc. To Contact The Firm

NEW YORK, NY / ACCESSWIRE / September 5, 2017 / Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Otonomy, Inc. ("Otonomy" or the "Company") (N...

Otonomy Swings Axe after Otividex Failure

Otonomy said today it will eliminate part of its workforce among actions intended to cut costs, extend its cash runway, and build shareholder value following the failure of its Ménière’s d...

Otonomy shares sink on Otividex failure

US ear disorders specialist Otonomy lost 83% of its market value on Wednesday after reporting disastrous…

Otonomy's OTIVIDEX Produces Positive Results from AVERTS-2 Phase III Trial

NewsThe company expects to provide an update from discussions with the FDA during the first quarter of 2018.

US FDA accepts Otonomy's Otiprio sNDA filing for acute otitis externa

Otonomy, Inc., a biopharmaceutical company focused on the development and commercialization of innovative therapeutics for diseases and disorders of the ear, announced that its Supplemental New Drug A...

Otonomy pulls plug on ear drug, shares nosedive

(Reuters) - Otonomy Inc said on Wednesday it suspended developing its drug for Meniere's disease, a chronic disorder of the inner ear, after it failed a late-stage trial, sending the drugmaker's share...

Otonomy's SNDA for expanded indication of Otiprio accepted for FDA review

The supplemental new drug application from Otonomy for the acute otitis externa indication of Otiprio has been accepted for r -More- 

Otonomy's ear disease drug fails key trial, shares nosedive

(Reuters) - U.S. drugmaker Otonomy Inc said on Wednesday it would stop developing its drug to treat Meniere's disease, a chronic, progressive disorder of the inner ear, after it failed a late-stage tr...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [2 Associated Clinical Trials listed on BioPortfolio]

A 6-Month Extension Study of OTO-104 in Meniere's Disease

This is an open-label extension study of a single intratympanic injection of OTO-104 given every 3 months for a total of 2 injections. Subjects must have completed either Otonomy study 104...

A 6-Month Extension Study of OTO-104 in Meniere's Disease

This is an open-label extension study of a single intratympanic injection of OTO-104 given every 3 months for a total of 2 injections. Subjects must have completed either Otonomy study 104...

Companies [2 Associated Companies listed on BioPortfolio]

Otonomy Inc.

Otonomy is an emerging biopharmaceutical company based in San Diego that is focused on the development and commercialization of novel treatments for diseases of the inner and middle ear. This field re...

Otonomy, Inc.

Otonomy is a clinical stage biopharmaceutical company developing novel drug therapies for disorders of the inner and middle ear. The company's core technology is a sustained release formulation develo...

More Information about "Otonomy Inc." on BioPortfolio

We have published hundreds of Otonomy Inc. news stories on BioPortfolio along with dozens of Otonomy Inc. Clinical Trials and PubMed Articles about Otonomy Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Otonomy Inc. Companies in our database. You can also find out about relevant Otonomy Inc. Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topic

Hearing
Hearing, auditory perception, or audition is the ability to perceive sound by detecting vibrations, changes in the pressure of the surrounding medium through time, through an organ such as the ear. Sound may be heard through solid, liquid, or gaseous mat...


Corporate Database Quicklinks



Searches Linking to this Company Record